Metraipolis › archive › dc_fb209ac2d4af
Identification of key genes predicting the efficacy of mepolizumab in the treatment of severe eosinophilic asthma — Europe PMC PMID:41225087
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41225087
- DOI
- 10.1038/s41598-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T15:09:57.336Z
- SHA-256 of the archived text
70f68fe89a897c4bac083d95407e2d470b677475a42366121486dd00d91377cf- Stable URL of this page
https://metraipolis.com/documento/dc_fb209ac2d4af
How to cite
Identification of key genes predicting the efficacy of mepolizumab in the treatment of severe eosinophilic asthma — Europe PMC PMID:41225087 — Europe PMC (en), https://europepmc.org/article/MED/41225087 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb209ac2d4af (Metraipolis archive dc_fb209ac2d4af, sha256 70f68fe89a897c4bac083d95407e2d470b677475a42366121486dd00d91377cf)
BibTeX
@misc{dcfb209ac2d4af,
title = {Identification of key genes predicting the efficacy of mepolizumab in the treatment of severe eosinophilic asthma — Europe PMC PMID:41225087},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41225087},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb209ac2d4af; sha256 70f68fe89a897c4bac083d95407e2d470b677475a42366121486dd00d91377cf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41225087. Agents can read the archived copy with the MCP tool read_document.